サンバイオの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/09/02 | 1,262 | 1,270 | 1,240 | 1,264 | +3 | +0.2% | 315,900 |
2021/09/01 | 1,216 | 1,263 | 1,202 | 1,261 | +66 | +5.5% | 544,800 |
2021/08/31 | 1,222 | 1,223 | 1,181 | 1,195 | -28 | -2.3% | 258,900 |
2021/08/30 | 1,200 | 1,224 | 1,194 | 1,223 | +30 | +2.5% | 201,100 |
2021/08/27 | 1,200 | 1,204 | 1,183 | 1,193 | -11 | -0.9% | 177,800 |
2021/08/26 | 1,185 | 1,208 | 1,173 | 1,204 | +25 | +2.1% | 185,100 |
2021/08/25 | 1,187 | 1,192 | 1,173 | 1,179 | -2 | -0.2% | 191,500 |
2021/08/24 | 1,213 | 1,213 | 1,177 | 1,181 | -17 | -1.4% | 180,600 |
2021/08/23 | 1,187 | 1,217 | 1,176 | 1,198 | +28 | +2.4% | 263,800 |
2021/08/20 | 1,156 | 1,186 | 1,150 | 1,170 | +11 | +0.9% | 276,400 |
2021/08/19 | 1,133 | 1,199 | 1,133 | 1,159 | +11 | +1% | 372,200 |
2021/08/18 | 1,111 | 1,150 | 1,109 | 1,148 | +28 | +2.5% | 201,200 |
2021/08/17 | 1,125 | 1,142 | 1,108 | 1,120 | -10 | -0.9% | 214,300 |
2021/08/16 | 1,140 | 1,153 | 1,102 | 1,130 | -27 | -2.3% | 246,900 |
2021/08/13 | 1,146 | 1,168 | 1,134 | 1,157 | +9 | +0.8% | 325,500 |
2021/08/12 | 1,112 | 1,163 | 1,112 | 1,148 | +42 | +3.8% | 379,500 |
2021/08/11 | 1,061 | 1,110 | 1,060 | 1,106 | +22 | +2% | 447,000 |
2021/08/10 | 1,040 | 1,090 | 1,012 | 1,084 | +24 | +2.3% | 781,900 |
2021/08/06 | 1,091 | 1,112 | 1,056 | 1,060 | -36 | -3.3% | 533,800 |
2021/08/05 | 1,093 | 1,132 | 1,082 | 1,096 | -12 | -1.1% | 384,400 |
2021/08/04 | 1,139 | 1,142 | 1,094 | 1,108 | -31 | -2.7% | 641,800 |
2021/08/03 | 1,165 | 1,171 | 1,138 | 1,139 | -33 | -2.8% | 406,900 |
2021/08/02 | 1,174 | 1,184 | 1,161 | 1,172 | -2 | -0.2% | 269,300 |
2021/07/30 | 1,201 | 1,201 | 1,164 | 1,174 | -27 | -2.2% | 403,500 |
2021/07/29 | 1,202 | 1,213 | 1,199 | 1,201 | +4 | +0.3% | 249,800 |
2021/07/28 | 1,220 | 1,220 | 1,193 | 1,197 | -25 | -2% | 372,900 |
2021/07/27 | 1,228 | 1,245 | 1,217 | 1,222 | -10 | -0.8% | 202,800 |
2021/07/26 | 1,222 | 1,254 | 1,222 | 1,232 | +12 | +1% | 187,300 |
2021/07/21 | 1,217 | 1,242 | 1,215 | 1,220 | +9 | +0.7% | 258,900 |
2021/07/20 | 1,200 | 1,224 | 1,198 | 1,211 | +6 | +0.5% | 343,700 |
2021/07/19 | 1,213 | 1,222 | 1,200 | 1,205 | -29 | -2.4% | 307,200 |
2021/07/16 | 1,235 | 1,243 | 1,217 | 1,234 | -6 | -0.5% | 332,700 |
2021/07/15 | 1,270 | 1,270 | 1,240 | 1,240 | -38 | -3% | 516,600 |
2021/07/14 | 1,265 | 1,281 | 1,255 | 1,278 | +6 | +0.5% | 275,800 |
2021/07/13 | 1,290 | 1,299 | 1,268 | 1,272 | -32 | -2.5% | 337,600 |
2021/07/12 | 1,297 | 1,308 | 1,281 | 1,304 | +18 | +1.4% | 387,700 |
2021/07/09 | 1,260 | 1,291 | 1,260 | 1,286 | -4 | -0.3% | 494,500 |
2021/07/08 | 1,327 | 1,327 | 1,282 | 1,290 | -47 | -3.5% | 631,500 |
2021/07/07 | 1,363 | 1,363 | 1,331 | 1,337 | -35 | -2.6% | 493,500 |
2021/07/06 | 1,385 | 1,435 | 1,363 | 1,372 | -21 | -1.5% | 491,700 |
2021/07/05 | 1,440 | 1,440 | 1,390 | 1,393 | -37 | -2.6% | 681,400 |
2021/07/02 | 1,444 | 1,457 | 1,419 | 1,430 | -55 | -3.7% | 460,800 |
2021/07/01 | 1,414 | 1,489 | 1,409 | 1,485 | +77 | +5.5% | 663,800 |
2021/06/30 | 1,432 | 1,437 | 1,403 | 1,408 | -22 | -1.5% | 382,400 |
2021/06/29 | 1,433 | 1,440 | 1,425 | 1,430 | -11 | -0.8% | 216,000 |
2021/06/28 | 1,443 | 1,454 | 1,429 | 1,441 | -5 | -0.3% | 207,200 |
2021/06/25 | 1,452 | 1,452 | 1,419 | 1,446 | -6 | -0.4% | 213,600 |
2021/06/24 | 1,455 | 1,478 | 1,446 | 1,452 | -17 | -1.2% | 205,000 |
2021/06/23 | 1,451 | 1,470 | 1,439 | 1,469 | +14 | +1% | 259,800 |
2021/06/22 | 1,425 | 1,457 | 1,411 | 1,455 | +51 | +3.6% | 392,600 |
901~
950
件表示中 / 2464件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サンバイオ | 240,900円 | - | - | 0.00% | - | 111.58倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
科研薬 | 386,700円 | +30.5% | +111.0% | 4.91% | 10.90倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 261,300円 | +13.9% | +6.6% | 2.68% | 6.81倍 | 0.81倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 237,400円 | +21.7% | +999.9% | 0.00% | 9.89倍 | 3.27倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム